Education
About Us
Working with TipRanks
Follow Us
FluoroPharma Medical Inc (FPMI)
OTHER OTC:FPMI
Total Valuation
FluoroPharma Medical has a market cap or net worth of $3.43K. The enterprise value is $0.00.
Market Cap$3.43K
Enterprise Value$0.00
Share Statistics
FluoroPharma Medical has 34,262,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding34,262,000
Owned by Insiders―
Owned by Institutions0.34%
Financial Efficiency
FluoroPharma Medical’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.00
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee0.00
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of FluoroPharma Medical is 0.00. FluoroPharma Medical’s PEG ratio is 0.00.
PE Ratio0.00
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, FluoroPharma Medical had revenue of 0.00 and earned 0.00 in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income0.00
Net Income0.00
EBITDA0.00
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -880.12K and capital expenditures 0.00, giving a free cash flow of -880.12K billion.
Operating Cash Flow-880.12K
Free Cash Flow-880.12K
Free Cash Flow per Share-0.03
Dividends & Yields
FluoroPharma Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.65
52-Week Price Change0.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
FluoroPharma Medical upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
FluoroPharma Medical as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, FluoroPharma Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
FluoroPharma Medical EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
FluoroPharma Medical has $24.72K in cash and marketable securities with $5.82M in debt, giving a net cash position of $5.80M billion.
Cash & Marketable Securities$24.72K
Total Debt$5.82M
Net Cash$5.80M
Net Cash Per Share$0.17
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for FluoroPharma Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―